Chief Financial Officer · LeonaBio, Inc. · Athira Pharma, Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
34.4K
Price
—
Executed
Dec 24, 2025
Disclosed
Dec 29, 2025
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Dec 24 executedDec 29, 2025 disclosed
ATHA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Renninger Robert filed this Form 4 reporting a grant or award of ATHA on Dec 24, 2025. It became public on Dec 29, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Renninger Robertcik:0002037968
Issuer
LeonaBio, Inc.cik:0001620463
Revision history · 0
No field has changed since this record was first ingested.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.
